Acer Therapeutics Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Acer Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2018 to Q3 2023.
  • Acer Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$1.85M, a 898% decline year-over-year.
  • Acer Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was -$21.1M, a 943% decline year-over-year.
  • Acer Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was -$1.62M, a 383% decline from 2021.
  • Acer Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $574K.
  • Acer Therapeutics Inc. annual Nonoperating Income (Expense) for 2020 was -$82.6K, a 117% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$21.1M -$1.85M -$2.09M -898% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$19M -$3.8M -$8.19M -186% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$10.8M -$11.3M -$9.16M -430% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$1.62M -$4.12M -$4.12M -449813% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-27
Q3 2022 $2.5M $232K +$226K +3893% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $2.27M $4.4M +$3.84M +684% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1.57M -$2.13M -$2.14M -24488% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $574K -$916 +$64.3K +98.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $510K $5.81K +$45K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $465K $561K +$562K Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-14
Q1 2021 -$96.6K $8.74K -$14K -61.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$82.6K -$65.2K -$101K -281% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 $18.7K -$39.2K -$150K -135% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-19
Q2 2020 $169K -$915 -$125K -101% Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-11-19
Q1 2020 $294K $22.7K -$185K -89.1% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-11-19
Q4 2019 $479K $36.1K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $111K -$30.9K -21.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $124K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $208K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q3 2018 $142K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.